<DOC>
	<DOCNO>NCT02776163</DOCNO>
	<brief_summary>This non-randomized , phase II , open label study postoperative current chemoradiotherapy high-risk malignant salivary gland tumor head neck.The primary purpose study evaluate efficacy safety concurrent chemoradiotherapy patient .</brief_summary>
	<brief_title>Postoperative Concurrent Chemoradiotherapy Treating Patients With High-Risk Malignant Salivary Gland Tumors</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Salivary Gland Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Pathologically proven diagnosis malignant salivary gland tumor intermediate highgrade 2 . Pathologic stage T34 N13 T12 , N0 close ( â‰¤ 5mm ) microscopically positive surgical margin 3 . Surgical resection curative intent within 8 week prior registration , evidence gross tumor residual 4 . No evidence distant metastases 5 . No synchronous concurrent head neck primary tumor 6 . Karnofsky score 60 7 . Adequate organ function include follow : 1 . Absolute neutrophil count ( ANC ) &gt; = 1.5 * 10^9/l 2 . Platelets count &gt; = 100 * 10^9/l 3 . Hemoglobin &gt; = 10 g/dl 4 . AST ALT &lt; = 2.5 time institutional upper limit normal ( ULN ) 5 . Total bilirubin &lt; = 1.5 time institutional ULN 6 . Creatinine clearance &gt; = 50 ml/min 7 . Serum creatine &lt; = 1 time ULN 8 . Signed write informed consent 1 . Evidence distant metastasis 2 . Prior chemotherapy anticancer biologic therapy type cancer , prior radiotherapy head neck region 3 . Other previous cancer , except situ cervical cancer cutaneous basal cell carcinoma 4 . Pregnant breastfeeding female , female male childbearing potential take adequate contraceptive measure 5 . Presence uncontrolled concomitant illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Salivary Gland Tumors</keyword>
	<keyword>Head-an-Neck cancer</keyword>
	<keyword>Concurrent Chemoradiotherapy</keyword>
	<keyword>High-Risk</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Docetaxel</keyword>
</DOC>